1. Home
  2. RVMD vs BFAM Comparison

RVMD vs BFAM Comparison

Compare RVMD & BFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • BFAM
  • Stock Information
  • Founded
  • RVMD 2014
  • BFAM 1986
  • Country
  • RVMD United States
  • BFAM United States
  • Employees
  • RVMD N/A
  • BFAM N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • BFAM Other Consumer Services
  • Sector
  • RVMD Health Care
  • BFAM Consumer Discretionary
  • Exchange
  • RVMD Nasdaq
  • BFAM Nasdaq
  • Market Cap
  • RVMD 8.7B
  • BFAM 7.9B
  • IPO Year
  • RVMD 2020
  • BFAM 1997
  • Fundamental
  • Price
  • RVMD $44.39
  • BFAM $109.70
  • Analyst Decision
  • RVMD Strong Buy
  • BFAM Buy
  • Analyst Count
  • RVMD 12
  • BFAM 8
  • Target Price
  • RVMD $64.67
  • BFAM $140.75
  • AVG Volume (30 Days)
  • RVMD 2.1M
  • BFAM 627.5K
  • Earning Date
  • RVMD 11-06-2024
  • BFAM 02-11-2025
  • Dividend Yield
  • RVMD N/A
  • BFAM N/A
  • EPS Growth
  • RVMD N/A
  • BFAM 34.24
  • EPS
  • RVMD N/A
  • BFAM 2.00
  • Revenue
  • RVMD $742,000.00
  • BFAM $2,627,515,000.00
  • Revenue This Year
  • RVMD N/A
  • BFAM $13.22
  • Revenue Next Year
  • RVMD $1,855.42
  • BFAM $7.85
  • P/E Ratio
  • RVMD N/A
  • BFAM $54.75
  • Revenue Growth
  • RVMD N/A
  • BFAM 12.67
  • 52 Week Low
  • RVMD $25.93
  • BFAM $91.61
  • 52 Week High
  • RVMD $62.40
  • BFAM $141.90
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 34.18
  • BFAM 42.30
  • Support Level
  • RVMD $42.53
  • BFAM $104.51
  • Resistance Level
  • RVMD $44.22
  • BFAM $120.29
  • Average True Range (ATR)
  • RVMD 1.59
  • BFAM 2.94
  • MACD
  • RVMD -0.27
  • BFAM 0.13
  • Stochastic Oscillator
  • RVMD 28.46
  • BFAM 32.89

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provides education and care solutions designed to help employers support their employees in managing their work/life balance. The company has three business segments: full-service center-based child care, backup care, and educational advisory services. The vast majority of the company's revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, tuition assistance, and education consulting. The company earns more than half of its revenue in North America.

Share on Social Networks: